Tyra Biosciences Cash Flow Statement (2020-2026) | TYRA

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-5.51M-6.64M-9.93M-14.83M-15.10M-12.52M-12.89M-11.88M-13.29M-21.15M-22.83M-18.19M-18.70M-24.02M-25.57M-28.15M-28.10M-29.87M-33.83M-39.30M
Depreciation and Depletion (Quarter)
26.00M41.00M-89.86M0.06M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M
Share-based Compensation (Quarter)
0.34M0.51M1.87M3.97M2.69M1.02M2.91M2.43M2.53M4.38M-1.04M2.70M4.41M7.57M12.30M3.70M6.38M4.10M7.63M7.85M
Gains from Investment Securities (Quarter)
1.22M2.09M-1.23M0.19M0.10M2.63M-0.73M0.54M0.78M8.11M4.00M32.24M0.10M0.02M-0.20M12.08M0.63M4.17M13.62M160.26M
Non-cash Items (Quarter)
5.40M28.90M24.50M21.80M1.26M13.49M1.98M2.21M42.30M40.42M3.66M50.37M4.51M33.80M58.30M5.46M6.10M186.67M5.97M
Cash from Operations (Quarter)
-4.46M-5.58M-9.03M-8.93M-17.17M-12.21M-11.98M-9.85M-9.62M-17.14M-13.53M-22.03M-10.26M-17.90M-19.59M-25.46M-23.68M-22.38M-23.62M-32.57M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.03M0.04M0.05M0.06M0.07M0.08M0.08M0.08M0.09M0.08M0.10M0.12M0.13M0.13M0.14M0.14M0.14M0.13M0.13M0.14M
Change in Working Capital
Change in Accured Expenses (Quarter)
0.74M1.23M0.10M1.56M0.54M0.05M0.21M-2.02M1.67M4.64M5.08M-6.91M1.94M2.01M2.21M-0.36M-0.49M2.07M2.16M1.20M
Investing Activities
Capital Expenditures (Quarter)
0.07M-0.11M0.64M0.24M-0.21M-0.02M-0.01M0.04M0.04M0.08M-0.04M0.14M0.47M0.05M-0.66M0.01M0.03M-0.02M0.04M0.02M
Change in Acquisitions & Divestments (Quarter)
30.00M32.88M58.00M45.00M38.91M41.00M50.41M43.54M42.05M
Cash from Investing Activities (Quarter)
-0.24M-0.24M-0.10M-0.24M-0.25M-0.05M-0.02M-0.04M-0.04M-0.08M-144.44M18.07M-144.99M21.56M6.96M32.03M20.87M-14.81M34.38M-120.24M
Financing Activities
Other financing activities (Quarter)
-183.46M
Change in Capital Stock
Shares Issued (Quarter)
-1.51M147.85M
Preferred Shares Issued (Quarter)
-82.61M
Misc.
Cash from Financing Activities (Quarter)
-0.73M183.44M-1.51M0.24M0.03M0.36M0.00M0.38M0.37M0.47M0.32M200.31M0.37M0.74M0.71M2.19M0.58M0.65M4.68M160.38M
Change in Cash (Quarter)
-5.43M177.62M-10.64M-8.93M-17.39M-11.90M-12.00M-9.51M-9.29M-16.76M-157.65M196.36M-154.88M4.40M-11.93M8.76M-2.23M-36.54M15.44M7.57M
Free Cash Flow (Quarter)
-4.53M-5.47M-9.67M-9.16M-16.96M-12.19M-11.97M-9.89M-9.66M-17.23M-13.49M-22.16M-10.73M-17.95M-18.93M-25.47M-23.71M-22.36M-23.67M-32.59M
Net Cash Flow (Quarter)
-5.43M177.62M-10.64M-8.93M-17.39M-11.90M-12.00M-9.51M-9.29M-16.76M-157.65M196.36M-154.88M4.40M-11.93M8.76M-2.23M-36.54M15.44M7.57M